Publications: Dr Thomas Erblich
Aries JA, Davies JK, Auer RL, Hallam SL, Montoto S, Smith M, Sevillano B, Foggo V et al.
(
2020
)
.
Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients
.
British Journal of Haematology
Erblich T, Hibbs S, Araf S, Butler T, Bowles L
(
2020
)
.
The feasibility and impact of teaching haematology registrars via a web-based videoconferencing system
.
BRITISH JOURNAL OF HAEMATOLOGY
.
vol.
189
,
195
-
195
.
Erblich T, Montoto S
(
2018
)
.
Treating relapsed follicular lymphoma
.
Expert Review of Hematology
vol.
11
,
(
5
)
403
-
410
.
Atkins O, Erblich T, Howard J, Malaspina A
(
2016
)
.
Paraproteinameia - a rare cause of a demyelinating neuropathy
.
BRITISH JOURNAL OF HAEMATOLOGY
.
vol.
173
,
171
-
172
.
Erblich T, Hill PD, Tomlinson J, Bain BJ
(
2015
)
.
The complex morphology of acute kidney injury with microangiopathic hemolytic anemia and hyposplenism
.
American Journal of Hematology
vol.
90
,
(
7
)
674
-
674
.
Zemenides S, Erblich T, Luqmani A, Bain BJ
(
2014
)
.
Peripheral blood features of acute myeloid leukemia with myelodysplasia-related changes developing in a patient with sickle cell anemia
.
American Journal of Hematology
vol.
89
,
(
10
)
Erblich T, Apperley J, Todd J, Salooja N
(
2014
)
.
CARDIOVASCULAR RISK FACTORS AND BODY HABITUS IN LONG TERM SURVIVORS OF STEM CELL TRANSPLANTATION
.
BONE MARROW TRANSPLANTATION
.
vol.
49
,
S277
-
S278
.
Palani R, Lasa M, Giles C, Erblich T, Patel A, Ghorashian S, Bray E, Loaiza S et al.
(
2014
)
.
HIGH DOSE ETOPOSIDE/GCSF IS A SAFE AND EFFECTIVE MOBILIZATION REGIMEN IN MULTIPLE MYELOMA: A SINGLE-INSTITUTION EXPERIENCE
.
BONE MARROW TRANSPLANTATION
.
vol.
49
,
S534
-
S534
.